Experience. Commitment. Results.
Opiant Pharmaceuticals, Inc. (OPNT), relating to its proposed acquisition by Indivior PLC. Under the terms of the agreement, OPNT shareholders will receive $20.00 in cash plus up to $8.00 per share in CVRs per share they own.
Luther Burbank Corp. (LBC), relating to its proposed acquisition by Washington Federal, Inc. Under the terms of the agreement, LBC shareholders will receive 0.3353 shares of Washington per share they own.
Washington Federal, Inc. (WAFD), relating to its proposed acquisition of Luther Burbank Corp.
Solid Biosciences, Inc. (SLDB), relating to its proposed merger with AavantiBio, Inc.
Benefitfocus, Inc. (BNFT), relating to its proposed acquisition by Voya Financial, Inc. Under the terms of the agreement, BNFT shareholders will receive $10.50 in cash per share they own.
SeaSpine Holdings Corp. (SPNE), relating to its proposed sale to Orthofix Medical Inc. Under the terms of the agreement, SeaSpine shareholders will own approximately 43.5% of the combined company
Atlas Corp. (ATCO), relating to its proposed sale to Poseidon Acquisition Corp. Under the terms of the agreement, ATCO shareholders will receive $15.50 in cash per share they own
ABIOMED, Inc. (ABMD), relating to its proposed acquisition by Johnson & Johnson. Under the terms of the tender offer, ABMD shareholders will receive $380.00 in cash per share they own.
Coffee Holding Co., Inc. (JVA), relating to its proposed merger with Delta Corp Holdings Ltd.
First Eagle Alternative Capital BDC, Inc. (FCRD), relating to its proposed sale to Crescent Capital BDC, Inc.